Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Thyroid (Late Stage^), 2014-2018

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Percentlate
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late ascending
US (SEER+NPCR) 1 *** 4.3 (4.3, 4.4) N/A 14,566 30.5
Hawaii 3 *** 5.3 (4.8, 5.8) 6 (2, 23) 82 39.1
Oregon 6 *** 5.1 (4.8, 5.4) 11 (4, 21) 220 37.6
California 3 *** 4.9 (4.8, 5.0) 14 (9, 19) 1,984 37.2
Colorado 6 *** 5.2 (4.9, 5.5) 8 (4, 17) 302 36.4
New Mexico 3 *** 5.6 (5.1, 6.1) 4 (2, 15) 120 35.5
Minnesota 6 *** 4.5 (4.2, 4.8) 23 (13, 30) 259 35.2
Idaho 3 *** 5.1 (4.6, 5.6) 10 (2, 26) 88 34.9
South Dakota 6 *** 5.0 (4.3, 5.8) 12 (2, 31) 42 34.8
Washington 5 *** 4.4 (4.2, 4.6) 25 (17, 30) 335 33.7
Connecticut 3 *** 6.0 (5.6, 6.3) 2 (1, 6) 222 33.0
Vermont 6 *** 4.8 (4.1, 5.7) 15 (2, 38) 32 33.0
New York 3 *** 6.5 (6.3, 6.6) 1 (1, 2) 1,334 32.9
Wisconsin 6 *** 4.6 (4.3, 4.8) 21 (12, 29) 276 32.7
Illinois 6 *** 4.8 (4.6, 4.9) 16 (10, 24) 635 32.3
Texas 6 *** 3.8 (3.7, 3.9) 34 (30, 40) 1,044 31.7
Utah 3 *** 5.5 (5.1, 5.9) 5 (2, 14) 154 31.6
Iowa 3 *** 4.6 (4.3, 5.0) 20 (9, 30) 147 31.1
Alaska 6 *** 3.9 (3.3, 4.6) 31 (13, 46) 29 30.9
North Dakota 6 *** 5.3 (4.5, 6.1) 7 (1, 29) 39 30.9
Missouri 6 *** 3.7 (3.5, 3.9) 38 (29, 43) 239 30.8
Montana 6 *** 4.4 (3.8, 5.0) 26 (8, 40) 48 30.8
Arizona 6 *** 4.1 (3.8, 4.3) 30 (24, 37) 289 30.7
Maryland 6 *** 4.3 (4.1, 4.5) 28 (18, 31) 267 30.5
Nebraska 6 *** 4.7 (4.3, 5.2) 19 (6, 30) 90 30.4
Maine 6 *** 4.7 (4.2, 5.3) 17 (4, 31) 68 29.8
Michigan 5 *** 3.8 (3.6, 3.9) 37 (29, 41) 392 29.8
Florida 6 *** 3.8 (3.7, 3.9) 35 (30, 40) 846 29.7
Virginia 6 *** 3.8 (3.6, 4.0) 33 (29, 41) 334 29.6
Nevada 6 *** 4.5 (4.2, 4.9) 22 (9, 31) 109 29.5
Rhode Island 6 *** 5.2 (4.6, 5.8) 9 (2, 28) 59 29.4
New Hampshire 6 *** 4.5 (4.0, 5.0) 24 (7, 36) 64 29.3
New Jersey 3 *** 5.6 (5.4, 5.8) 3 (2, 9) 527 29.3
North Carolina 6 *** 3.6 (3.4, 3.7) 39 (32, 43) 377 29.3
Delaware 6 *** 4.7 (4.1, 5.4) 18 (3, 35) 46 27.9
District of Columbia 6 *** 3.4 (2.8, 4.1) 42 (24, 48) 25 27.9
Indiana 6 *** 3.4 (3.2, 3.6) 43 (37, 46) 229 27.3
Wyoming 6 *** 4.2 (3.5, 5.0) 29 (6, 45) 24 27.1
Kentucky 3 *** 4.3 (4.0, 4.6) 27 (16, 31) 199 27.0
Pennsylvania 6 *** 5.0 (4.8, 5.2) 13 (7, 19) 682 26.5
Tennessee 6 *** 3.2 (3.1, 3.4) 45 (40, 47) 227 26.4
Georgia 3 *** 3.3 (3.1, 3.4) 44 (40, 46) 343 26.3
South Carolina 6 *** 2.8 (2.6, 3.0) 48 (45, 49) 148 25.5
Ohio 6 *** 3.8 (3.6, 4.0) 32 (29, 40) 463 24.8
Kansas 6 *** 3.8 (3.4, 4.1) 36 (27, 44) 111 24.3
Mississippi 6 *** 2.4 (2.2, 2.7) 49 (47, 50) 74 23.8
Alabama 6 *** 2.3 (2.1, 2.5) 50 (48, 50) 122 23.5
Louisiana 3 *** 3.5 (3.2, 3.7) 41 (32, 45) 169 23.5
Arkansas 6 *** 3.0 (2.7, 3.2) 46 (41, 49) 92 23.3
Oklahoma 6 *** 2.9 (2.6, 3.1) 47 (44, 49) 116 22.9
West Virginia 6 *** 3.5 (3.2, 4.0) 40 (29, 46) 69 20.3
Puerto Rico 6 *** 4.7 (4.4, 5.0) N/A 171 16.7
Massachusetts 3 ***
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 10/26/2021 6:35 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Coding is generally based on Surveillance, Epidemiology, and End Results (SEER) summary stage but may include other staging variables if necessary.
*** No Healthy People 2020 Objective for this cancer.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
3 Source: SEER November 2020 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2020 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top